Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jul-24 4:17 PM View:  | Intellia Therapeutics, Inc. (NTLA) | 22-Jul-24 | Grant | 66,324 | -- | -- | 100% 0 to 66.32K | |
| 05-Mar-24 4:24 PM View: | Fate Therapeutics Inc (FATE) | 04-Mar-24 | Sale (Planned) | 2,447 | $7.77 | $19,013.20 | (2%) 103.93K to 101.48K | |
| 30-Jan-24 4:01 PM View: | Fate Therapeutics Inc (FATE) | 29-Jan-24 | Sale (Planned) | 1,849 | $5.00 | $9,245.00 | (2%) 105.78K to 103.93K | |
| 10-Jan-24 4:29 PM View: | Fate Therapeutics Inc (FATE) | 09-Jan-24 | Sale | 7,028 | $4.37 | $30,712.40 | (6%) 112.8K to 105.78K | |
| 03-Jan-24 4:03 PM View: | Fate Therapeutics Inc (FATE) | 02-Jan-24 | Sale (Planned) | 5,182 | $3.66 | $18,966.10 | (4%) 117.98K to 112.8K | |
| 19-Dec-23 4:01 PM View: | Fate Therapeutics Inc (FATE) | 18-Dec-23 | Sale (Planned) | 1,585 | $3.50 | $5,547.50 | (1%) 119.57K to 117.98K | |
| 21-Aug-23 4:02 PM View: | Fate Therapeutics Inc (FATE) | 18-Aug-23 | Sale | 4,718 | $2.80 | $13,210.40 | (4%) 124.29K to 119.57K | |
| 06-Jul-23 5:18 PM View: | Fate Therapeutics Inc (FATE) | 05-Jul-23 | Sale (Planned) | 5,182 | $4.83 | $25,029.10 | (4%) 129.47K to 124.29K | |
| 11-Jan-23 4:06 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-23 | Sale | 7,331 | $5.24 | $38,414.40 | (5%) 136.8K to 129.47K | |
| 19-Aug-22 6:58 PM View: | Fate Therapeutics Inc (FATE) | 18-Aug-22 | Sale | 5,135 | $29.81 | $153,051.00 | (4%) 141.94K to 136.8K | |
| 27-Jan-22 4:35 PM View: | Fate Therapeutics Inc (FATE) | 25-Jan-22 | Grant | 33,302 | -- | -- | 31% 108.63K to 141.94K | |
| 13-Jan-22 4:06 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-22 | Market Sale | 1,770 | $48.45 | $85,757.40 | (2%) 110.4K to 108.63K | (2%) |
| 21-Dec-21 4:08 PM View: | Fate Therapeutics Inc (FATE) | 20-Dec-21 | Option Exercise | 14,437 | $35.52 | $512,802.00 | 13% 111.94K to 126.38K | |
| 21-Dec-21 4:08 PM View: | Fate Therapeutics Inc (FATE) | 20-Dec-21 | Market Option Sale (Planned) | 14,437 | $60.00 | $866,220.00 | (11%) 126.38K to 111.94K | |
| 21-Dec-21 4:08 PM View: | Fate Therapeutics Inc (FATE) | 20-Dec-21 | Market Sale (Planned) | 1,540 | $60.00 | $92,400.00 | (1%) 111.94K to 110.4K | |
| 22-Nov-21 5:41 PM View: | Fate Therapeutics Inc (FATE) | 19-Nov-21 | Grant | 59,540 | -- | -- | 114% 52.4K to 111.94K | |
| 30-Sep-21 4:14 PM View: | Fate Therapeutics Inc (FATE) | 28-Sep-21 | Option Exercise | 17,325 | $35.52 | $615,384.00 | 32% 54.54K to 71.86K | |
| 30-Sep-21 4:14 PM View: | Fate Therapeutics Inc (FATE) | 28-Sep-21 | Market Option Sale (Planned) | 17,325 | $62.53 | $1,083,330.00 | (24%) 71.86K to 54.54K | |
| 30-Sep-21 4:14 PM View: | Fate Therapeutics Inc (FATE) | 28-Sep-21 | Market Sale (Planned) | 2,135 | $62.53 | $133,502.00 | (4%) 54.54K to 52.4K | |
| 22-Jan-21 6:18 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-21 | Grant | 18,013 | -- | -- | 45% 40.0K to 58.01K | |
| 19-Aug-20 4:12 PM View: | Fate Therapeutics Inc (FATE) | 17-Aug-20 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K |